+13.1%
GSK vs STLA
-53.0%
+66.1%
-22.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | STLA | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.0% | +3.8% | +1.2% | +4.8% |
| 7D | +4.9% | -0.6% | +5.6% | +5.0% |
| 30D | +9.9% | +3.6% | +6.3% | +9.7% |
| 3M | +0.2% | -20.6% | +20.8% | +2.3% |
| 6M | +2.3% | -34.3% | +36.6% | +6.1% |
| YTD | +7.1% | -57.3% | +64.4% | +14.2% |
| 1Y | +13.1% | -52.6% | +65.8% | +18.2% |
| All | +13.1% | -53.0% | +66.1% | +18.2% |
Cumulative growth
Daily Returns
Daily percentage return beside STLA.
Daily Out/Under-Performance
Portfolio return minus STLA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × STLA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded STLA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling